HGNC Family | PRAME family (PRAMEF) |
Name | PRAME family member 10 |
Description | Predicted to enable ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be part of Cul2-RING ubiquitin ligase complex. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Mar 2025] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nFGF16 was first characterized through cloning and expression studies that revealed a high degree of evolutionary conservation between mouse and human transcripts and a predominant expression in cardiac tissue. Detailed promoter analyses further identified cardiac‐specific regulatory elements—such as a MEF2 binding site—coupled with chromatin remodeling events that ensure its selective transcription in the postnatal heart ("}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ").\n\nFunctional investigations have demonstrated that FGF16 plays a critical role in heart development and repair. During embryogenesis, it promotes myocardial growth, proper trabeculation, and cardiomyocyte proliferation, while its deficiency leads to chamber dilation, wall thinning, and reduced cell numbers. In the neonatal and postnatal heart, FGF16 not only supports regeneration by enhancing cardiomyocyte replication but also appears to counteract adverse remodeling—acting, at least in part, by antagonizing FGF2-induced TGF-β1 signaling to mitigate hypertrophy and fibrosis ("}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "8"}]}, {"type": "t", "text": ").\n\nAn additional regulatory dimension has been revealed in studies showing that post-transcriptional m6A modification—mediated by the methyltransferase Mettl3 and its effector Ythdf2—negatively regulates FGF16 mRNA levels. This m6A-dependent pathway modulates cardiomyocyte proliferation and is essential for efficient heart regeneration following injury ("}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ").\n\nOutside of cardiac biology, FGF16 is transiently expressed in the developing inner ear, where its localization in the otic cup and vesicle suggests a role in sensory epithelial patterning, even though its ablation does not produce overt defects in otic development. Moreover, overexpression studies have implicated FGF16 in metabolic regulation by inducing brown adipose tissue–like features in white fat depots and altering bile acid metabolism, although these systemic effects appear to be complex and multifactorial ("}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "12"}]}, {"type": "t", "text": ").\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "David P Sontag, Peter A Cattini "}, {"type": "b", "children": [{"type": "t", "text": "Cloning and bacterial expression of postnatal mouse heart FGF-16."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12619867"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12619867"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Alina G Sofronescu, Yan Jin, Peter A Cattini "}, {"type": "b", "children": [{"type": "t", "text": "A myocyte enhancer factor 2 (MEF2) site located in a hypersensitive region of the FGF16 gene locus is required for preferential promoter activity in neonatal cardiac myocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2007.0689"}], "href": "https://doi.org/10.1089/dna.2007.0689"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18260768"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18260768"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Shun Yan Lu, Farah Sheikh, Patricia C Sheppard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FGF-16 is required for embryonic heart development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2008.06.029"}], "href": "https://doi.org/10.1016/j.bbrc.2008.06.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18565327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18565327"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yuhei Hotta, Sayaka Sasaki, Morichika Konishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Dyn (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dvdy.21726"}], "href": "https://doi.org/10.1002/dvdy.21726"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18816849"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18816849"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Alina G Sofronescu, Karen A Detillieux, Peter A Cattini "}, {"type": "b", "children": [{"type": "t", "text": "FGF-16 is a target for adrenergic stimulation through NF-kappaB activation in postnatal cardiac cells and adult mouse heart."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cvr/cvq025"}], "href": "https://doi.org/10.1093/cvr/cvq025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20097674"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20097674"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Shun Yan Lu, Yan Jin, Xiaodong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Embryonic survival and severity of cardiac and craniofacial defects are affected by genetic background in fibroblast growth factor-16 null mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2010.1024"}], "href": "https://doi.org/10.1089/dna.2010.1024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20618076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20618076"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Emi Matsumoto, Sayaka Sasaki, Hideyuki Kinoshita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Cells (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/gtc.12055"}], "href": "https://doi.org/10.1111/gtc.12055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23600527"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23600527"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wei Yu, Xiuzhen Huang, Xueying Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GATA4 regulates Fgf16 to promote heart repair after injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Development (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/dev.130971"}], "href": "https://doi.org/10.1242/dev.130971"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26893347"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26893347"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Fu-Qing Jiang, Kun Liu, Jia-Xuan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mettl3-mediated m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.77014"}], "href": "https://doi.org/10.7554/eLife.77014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36399125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36399125"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Tracy J Wright, Ekaterina P Hatch, Hakan Karabagli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of mouse fibroblast growth factor and fibroblast growth factor receptor genes during early inner ear development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Dyn (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dvdy.10362"}], "href": "https://doi.org/10.1002/dvdy.10362"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14517998"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14517998"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ekaterina P Hatch, Lisa D Urness, Suzanne L Mansour "}, {"type": "b", "children": [{"type": "t", "text": "Fgf16(IRESCre) mice: a tool to inactivate genes expressed in inner ear cristae and spiral prominence epithelium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Dyn (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/dvdy.21681"}], "href": "https://doi.org/10.1002/dvdy.21681"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18773497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18773497"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Ingrid C Rulifson, Patrick Collins, Li Miao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In Vitro and in Vivo Analyses Reveal Profound Effects of Fibroblast Growth Factor 16 as a Metabolic Regulator."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M116.751404"}], "href": "https://doi.org/10.1074/jbc.M116.751404"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28011645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28011645"}]}]}]}
|
Proteins | PRA10_HUMAN |
NCBI Gene ID | 343071 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
PRAMEF10 has 1,088 functional associations with biological entities spanning 7 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 38 datasets.
Click the + buttons to view associations for PRAMEF10 from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PRAMEF10 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PRAMEF10 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRAMEF10 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PRAMEF10 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRAMEF10 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PRAMEF10 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PRAMEF10 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PRAMEF10 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRAMEF10 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with PRAMEF10 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PRAMEF10 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PRAMEF10 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PRAMEF10 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of PRAMEF10 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PRAMEF10 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PRAMEF10 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRAMEF10 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PRAMEF10 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PRAMEF10 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PRAMEF10 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GO Biological Process Annotations 2025 | biological processes involving PRAMEF10 gene from the curated GO Biological Process Annotations2025 dataset. | |
GO Cellular Component Annotations 2025 | cellular components containing PRAMEF10 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by PRAMEF10 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PRAMEF10 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PRAMEF10 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PRAMEF10 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PRAMEF10 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PRAMEF10 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PRAMEF10 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of PRAMEF10 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PRAMEF10 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MiRTarBase microRNA Targets | microRNAs targeting PRAMEF10 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PRAMEF10 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for PRAMEF10 from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PRAMEF10 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PRAMEF10 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PRAMEF10 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PRAMEF10 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |